Katie Hasson

Katie Hasson, PhD, writes, speaks, researches, and teaches about the social and political aspects of human genetic and reproductive technologies. Katie earned her PhD in Sociology with a Designated Emphasis in Women, Gender, and Sexuality from the University of California, Berkeley, and was previously Assistant Professor of Sociology and Gender Studies at the University of Southern California.

Profile picture for user Katie Hasson

Publications

DNA Code
By Katie Hasson, Impact Ethics | 12.04.2020

The “CRISPR babies” announced in headlines around the world recently turned two years old, and we still know nothing about...

Map of the world showing countries that prohibit heritable human genome editing in red
By Françoise Baylis, Marcy Darnovsky, Katie Hasson, and Timothy M. Krahn, The CRISPR Journal | 10.20.2020

Abstract

Discussions and debates about the governance of human germline and heritable genome editing should be informed by a clear...

CRISPR
By Katie Hasson and Marcy Darnovsky, The Hill | 09.13.2020

In November 2018, at a gene-editing “summit” hosted by scientific societies from the U.S., the U.K., and Hong...

In the News

eugenics graphic
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025

A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's...

DNA graphic
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025

In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology...

genetic selection graphic
By Brittany Luse, Liam McBain, and Neena Pathak, NPR [cites CGS' Katie Hasson] | 05.28.2025

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer...

Biopolitical Times

This month’s gene therapy news includes celebrations of promising new developments running beside gloomy takes on the future of the...

In a much-anticipated move, US regulators have approved two new gene therapies for sickle cell disease. On December 8...

Any coverage of heritable genome editing since 2018 has to include discussion of the reckless experiments of He Jiankui and...